blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1451197

EP1451197 - 4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO-[3.2.2]-NONANE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF [Right-click to bookmark this link]
Former [2004/36]4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO- 3.2.2 NONANE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
[2007/15]
StatusNo opposition filed within time limit
Status updated on  07.03.2008
Database last updated on 11.09.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR
published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
Sanofi-Aventis
174, Avenue de France
75013 Paris / FR
[2004/44]
Former [2004/36]For all designated states
SANOFI-SYNTHELABO
174, Avenue de France
75013 Paris / FR
Inventor(s)01 / GALLI, Frédéric
6, avenue de Rueil
F-92420 Vaucresson / FR
02 / LECLERC, Odile
11, rue Winston Churchill
F-91300 Massy / FR
03 / LOCHEAD, Alistair
95, rue de Paris
F-94220 Charenton le Pont / FR
 [2004/36]
Representative(s)Ludwig, Jacques, et al
Sanofi-Aventis 174 avenue de France
75013 Paris / FR
[N/P]
Former [2004/36]Ludwig, Jacques, et al
Sanofi-Synthélabo Service Brevets 174, avenue de France
75013 Paris / FR
Application number, filing date02803450.220.11.2002
[2004/36]
WO2002FR03978
Priority number, dateFR2001001515223.11.2001         Original published format: FR 0115152
[2004/36]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO03044024
Date:30.05.2003
Language:FR
[2003/22]
Type: A1 Application with search report 
No.:EP1451197
Date:01.09.2004
Language:FR
The application published by WIPO in one of the EPO official languages on 30.05.2003 takes the place of the publication of the European patent application.
[2004/36]
Type: B1 Patent specification 
No.:EP1451197
Date:02.05.2007
Language:FR
[2007/18]
Search report(s)International search report - published on:EP30.05.2003
ClassificationIPC:C07D519/00, A61K31/551, A61P25/28, A61P25/16
[2004/36]
CPC:
C07D519/00 (EP,US); A61P25/00 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P25/32 (EP); A61P25/34 (EP); A61P39/02 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/36]
Extension statesAL23.06.2004
LT23.06.2004
LV23.06.2004
MK23.06.2004
RO23.06.2004
SI23.06.2004
TitleGerman:4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO-[3.2.2]-NONANDERIVATE, DEREN HERSTELLUNG UND DEREN THERAPEUTISCHE VERWENDUNG[2007/15]
English:4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO-[3.2.2]-NONANE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF[2007/15]
French:DERIVES DE 4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO-[3.2.2]-NONANE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE[2007/15]
Former [2004/36]4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLOç3.2.2!NONANDERIVATE, DEREN HERSTELLUNG UND DEREN THERAPEUTISCHE VERWENDUNG
Former [2004/36]4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO- 3.2.2 NONANE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
Former [2004/36]DERIVES DE 4-(OXAZOLOPYRIDIN-2-YL)-1,4-DIAZABICYCLO 3.2.2 NONANE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
Entry into regional phase23.06.2004National basic fee paid 
23.06.2004Designation fee(s) paid 
23.06.2004Examination fee paid 
Examination procedure02.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.06.2004Examination requested  [2004/36]
19.08.2005Despatch of a communication from the examining division (Time limit: M04)
05.12.2005Reply to a communication from the examining division
07.09.2006Communication of intention to grant the patent
17.01.2007Fee for grant paid
17.01.2007Fee for publishing/printing paid
Opposition(s)05.02.2008No opposition filed within time limit [2008/15]
Fees paidRenewal fee
25.11.2004Renewal fee patent year 03
28.11.2005Renewal fee patent year 04
27.11.2006Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.05.2007
CY02.05.2007
CZ02.05.2007
DK02.05.2007
EE02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
TR02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
LU20.11.2007
BE30.11.2007
CH30.11.2007
LI30.11.2007
MC30.11.2007
[2009/42]
Former [2009/38]AT02.05.2007
CY02.05.2007
CZ02.05.2007
DK02.05.2007
EE02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
LU20.11.2007
BE30.11.2007
CH30.11.2007
LI30.11.2007
MC30.11.2007
Former [2009/34]AT02.05.2007
CY02.05.2007
CZ02.05.2007
DK02.05.2007
EE02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
BE30.11.2007
CH30.11.2007
LI30.11.2007
MC30.11.2007
Former [2009/10]AT02.05.2007
CZ02.05.2007
DK02.05.2007
EE02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
BE30.11.2007
CH30.11.2007
LI30.11.2007
MC30.11.2007
Former [2008/43]AT02.05.2007
CZ02.05.2007
DK02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
BE30.11.2007
CH30.11.2007
LI30.11.2007
MC30.11.2007
Former [2008/35]AT02.05.2007
CZ02.05.2007
DK02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
CH30.11.2007
LI30.11.2007
MC30.11.2007
Former [2008/29]AT02.05.2007
CZ02.05.2007
DK02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
MC30.11.2007
Former [2008/22]AT02.05.2007
CZ02.05.2007
DK02.05.2007
FI02.05.2007
IE02.05.2007
IT02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
GR03.08.2007
ES13.08.2007
PT02.10.2007
Former [2008/13]AT02.05.2007
CZ02.05.2007
DK02.05.2007
FI02.05.2007
IE02.05.2007
NL02.05.2007
SK02.05.2007
BG02.08.2007
SE02.08.2007
ES13.08.2007
PT02.10.2007
Former [2008/10]AT02.05.2007
CZ02.05.2007
DK02.05.2007
FI02.05.2007
IE02.05.2007
NL02.05.2007
BG02.08.2007
SE02.08.2007
ES13.08.2007
PT02.10.2007
Former [2008/09]AT02.05.2007
DK02.05.2007
FI02.05.2007
NL02.05.2007
BG02.08.2007
SE02.08.2007
ES13.08.2007
Former [2008/08]AT02.05.2007
DK02.05.2007
FI02.05.2007
SE02.08.2007
ES13.08.2007
Former [2007/50]AT02.05.2007
FI02.05.2007
SE02.08.2007
ES13.08.2007
Former [2007/49]FI02.05.2007
SE02.08.2007
ES13.08.2007
Former [2007/47]ES13.08.2007
Cited inInternational search[A]US4826848  (JANSSENS FRANS E [BE], et al) [A] 1-3 * claim 1 *;
 [A]WO0034279  (SANOFI SYNTHELABO [FR], et al) [A] 1-3 * claim - *;
 [E]EP1219622  (PFIZER PROD INC [US]) [E] 1-3* examples 1,8,18-27,29,31-48 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.